Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues Citi Q1 2026 Earnings EPS Surpasses Estimates by 133 Amid Improved Operational Efficiency Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline KTCC Q1 2026 Earnings Loss Per Share of 026 as Stock Declines 17